[CLSTR]
API
< Back to situation

[REVISION HISTORY]

HPV vaccination and testing initiatives in Brazil

14 recorded revisions of this situation.

What changed

2026-11-03 05:12 UTC → 2026-11-04 12:14 UTC · added removed

Public health initiatives regarding the HPV vaccine in Brazil have focused on local awareness campaigns and national policy expansions. In Paraíba, the ‘Setembro em Flor’ campaign utilized ‘Dia D’ mobilizations in João Pessoa, employing mobile vaccination points at shopping malls and supermarkets to increase accessibility for children and adolescents aged 9 to 14, as well as those aged 15 to 19 seeking to update their status. Nationally, the Ministry of Health has expanded target groups to include children aged 2 to 8 of both sexes who are victims of sexual violence. Clinical data highlights the impact of vaccination through the Unified Health System (SUS). A study in Human Vaccines & Immunotherapeutics shows that consultations for pre-cancerous cervical lesions among adolescents have dropped by nearly 78%. Specifically, consultations for HPV-related lesions fell from 603 in 2015 to 136 in 2023, with the rate per 100,000 adolescents dropping from 7.1 to 1.8. Complementing vaccination, the SUS is implementing DNA-HPV molecular testing to improve early detection of cervical cancer by identifying high-risk types, such as 16 and 18, before physical lesions appear. This technology allows for a longer screening interval of five years for patients with negative results. The rollout has reached 26 states and the Federal District, though Espírito Santo has not yet implemented the strategy, with materials expected in 2026. Testing is conducted at Basic Health Units (UBS), where self-collection may be an option under professional guidance. Recent data shows that of 153,000 samples collected between 2025 and 2026, 9,904 of the 93,000 processed in 2026 tested positive for high-risk HPV. The molecular testing, which utilizes kits manufactured by In November 2026, the Institute of Molecular Biology Ministry of Paraná (IBMP/Fiocruz), is being progressively integrated Health published 18 updated documents to replace guide the Pap smear as prevention, diagnosis, treatment, and follow-up of various cancers within the primary detection method. SUS.

Versions

  1. 2026-11-04 12:14 UTC HPV vaccination and testing initiatives in Brazil
  2. 2026-11-03 05:12 UTC HPV vaccination and testing initiatives in Brazil
  3. 2026-11-01 08:42 UTC HPV vaccination and testing initiatives in Brazil
  4. 2026-10-30 23:45 UTC HPV vaccination and testing initiatives in Brazil
  5. 2026-10-30 20:50 UTC HPV vaccination and testing initiatives in Brazil
  6. 2026-10-30 17:01 UTC HPV vaccination and testing initiatives in Brazil
  7. 2026-10-29 13:07 UTC HPV vaccination and testing initiatives in Brazil
  8. 2026-10-27 02:42 UTC HPV vaccination and testing initiatives in Brazil
  9. 2026-10-25 17:08 UTC HPV vaccination and testing initiatives in Brazil
  10. 2026-10-20 21:03 UTC HPV vaccination initiatives and impact in Brazil
  11. 2026-10-20 01:24 UTC HPV vaccination initiatives and impact in Brazil
  12. 2026-10-07 17:53 UTC HPV vaccination initiatives in Brazil
  13. 2026-09-26 23:00 UTC HPV vaccination initiatives in Brazil
  14. 2026-09-26 19:50 UTC HPV vaccination initiatives in Brazil
  15. 2026-09-17 14:08 UTC HPV vaccination initiatives in Brazil

Select a version to see what changed compared to the one before it.